ICR Consilium's Annual Healthcare Conference, sponsored by Citi, Cooley and Stifel is now in its 11th year and brought together leading experts from the healthcare and biotechnology industries to discuss the key themes and issues currently facing the sector.

Thank you to all attendees, speakers, and sponsors for the event. We look forward to welcoming you all back next year, at our 12th Annual Healthcare Conference.

Information

View

close

Information

Time: 12:00-18:30

Address: One Moorgate Place, Chartered Accountants' Hall, 1 Moorgate Pl, London EC2R 6EA

Closest tube stations: Bank, St Paul’s, Moorgate, Liverpool Street

 

Nearby hotels: Apex London Wall, South Place Hotel, Threadneedles

 

Lunch and refreshments will be provided.

 

Live webcast of the event will also be available closer the time.

 

If you have any questions, please contact admincsc@consilium-comms.com.

Speakers

View

close

Speakers

ICR Consilium's 11th Annual Healthcare Conference Speaker list

12:00 - 1312:00 - 1

 

Stephane Boissel, President and Chief Executive Officer

SparingVision

Picture of Stephane Boissell

 

Bharatt Chowrira, President and Chief Business, Legal and Operating Officer

PureTech Health

 

Bev Carr, Interim Chief Executive Officer

Amphista Therapeutics

 

Chris Hollowood, Chief Executive Officer

Syncona

Picture of Chris Hollowood

 

Dima Kuzmin, Managing Partner

4BIO Capital

Picture of Dima Kuzmin

 

Alan MacKay, Managing Partner & Founder

GHO Capital

Picture of Alan MacKay

 

Paul M. Matthews, Professor and Head of the Department of Brain Sciences

Imperial College London

Picture of Paul Matthews

 

Jack O'Meara, Chief Executive Officer and Co-Founder

Ochre Biotech

Picture of Jack O'Meara

 

Jorge de Santos Da Silva, Founder and Chief Executive Officer

MoonLake Immunotherapeutics

Picture of Jorge Santos de Silva

 

 

Phillip Scheltens, Managing Partner

LSP Dementia Fund, EQT Life Sciences

Picture of Philip Schelten

 

 

 

Riad Sherif, Chief Executive Officer

Oculis

 Picture of Riad Sherif

 

Sarah Skerratt, Head of Drug Discovery

CHARM Therapeutics

Picture of Sarah Skerratt

 

John Tsai, Chief Executive Officer

Forcefield Therapeutics

Picture of John Tsai

 

 

Alan P. Watt, Chief Executive Officer

NodThera

Picture of Alan Watt

 

 

Alethia Young, Chief Financial Officer

Bicycle Therapeutics

Picture of Alethia Young

Agenda

View

close

Agenda

12:00 – 13:00

Lunch and networking

13:00 – 13:05

Introduction from Amber Fennell, Senior Partner, ICR Consilium

13:05 – 13:50

PANEL 1: Enabling the future of healthcare: the technologies changing the face of medicine

AI powered drug discovery, precision RNA and genomic medicines are just some of the technologies radically changing medicine. How can we best ensure the success of these approaches and ensure all patients can access them?

13:50 – 14:35

PANEL 2: Are we nearly there yet?

Private financing has dominated the sector recently and although public markets are showing signs of life, caution remains the watchword.

Our panel talks about how to play the current financing outlook.

14:35 – 15:20

Break

15:20 – 16:05

PANEL 3: The brain: the final healthcare frontier

This panel explores how giant leaps forward in neuroscience and knowledge around how the brain impacts chronic and peripheral disease

16:05 – 16:50

FIRESIDE CHAT:

A veteran of Novartis and Amgen now moving to a young company, John Tsai talks Big Pharma, startups and innovation

16:50 – 17:00

Closing remarks

17:00 – 18:30

Networking drinks